Re-irradiation for high-grade gliomas: Has anything changed?
Open Access
- 24 September 2021
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 12 (9) , 767-786
Abstract
Re-irradiation for high-grade gliomas: Has anything changed?Keywords
This publication has 114 references indexed in Scilit:
- Reirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohortRadiation Oncology, 2013
- External Beam Radiotherapy of Recurrent Glioma: Radiation Tolerance of the Human BrainCancers, 2012
- Safety and Efficacy of Stereotactic Radiosurgery and Adjuvant Bevacizumab in Patients With Recurrent Malignant GliomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?Neuro-Oncology, 2011
- Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastomaJournal of Neuro-Oncology, 2010
- Radiation Associated Brainstem InjuryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant GliomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005